News on haematological malignancies
Taming a fatal blood cancer
When a dangerous defect on chromosome 11q23 disrupts the genetic programming of blood cells, it…
News on haematological malignancies
When a dangerous defect on chromosome 11q23 disrupts the genetic programming of blood cells, it…
Results from the OPTIMISMM study, a phase III, randomised, open-label, international clinical study of the…
People with a slow developing type of blood cancer may be able to safely come…
Survival times for a highly aggressive type of blood cancer have nearly doubled over the…
Treatment changes including the advent of targeted and immune therapies have dramatically improved survival for…
Austrian researchers have discovered that a small number of patients taking targeted drugs known as…
New research, led by cancer biologists from the University of Bristol, has shown that bone…
A new study by researchers from the University of Chicago Medicine shows that bacterial signals…
Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest…
The majority of patients with diffuse large B cell lymphoma (DLBCL) can be treated effectively.…